TNF Inhibitors Exert a "Hidden" Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients.

Jaime Calvo Alén Bernardo Alio Lavin-GomezElena AurrecoecheaArmando Raúl Guerra RuizVíctor Martínez TaboadaJuan Gómez Gerique

Published in: Biologics : targets & therapy (2022)

TNFi treatment was associated with beneficial atherogenic effects at the lipoprotein level especially centered in the VLDL-related parameters consistent with a reduction of the atherogenic risk.

Keyphrases

end stage renal disease
low density lipoprotein
rheumatoid arthritis
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
disease activity